Hormonal side effects in women: Typical versus atypical antipsychotic treatment

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 3, 2000, Pages 10-15

  Dickson, Ruth A ^a,d   Seeman, Mary V ^c   Corenblum, Bernard ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Calgary General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; QUETIAPINE; RISPERIDONE; TRIFLUOPERAZINE;

ARTICLE; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INFERTILITY; MENSTRUATION DISORDER; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA; SEXUAL DYSFUNCTION;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; GALACTORRHEA; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; MENSTRUATION DISTURBANCES; MIDDLE AGED; PROLACTIN; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 0034013665     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Rubin RT. Prolactin and schizophrenia. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:803-808
2. Meltzer HY, Goode DJ, Schyve PM, et al. Effect of clozapine on human serum prolactin levels. Am J Psychiatry 1979;136:1550-1555
3. Tollefson GD, Beasley CM Jr, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997;154:457-465
4. Tran PV, Hamilton SH, Kuntz AJ, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997;17:407-418
5. Crawford AMK, Beasley CM Jr, Tollefson GD. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophr Res 1997;28:224-267
6. Arvanitis LA, Miller BG. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 1997;42:233-246
7. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Schizophrenia. Am J Psychiatry 1997;154(suppl 4):1-63
8. Peuskins J. Risperidone in the treatment of patients with chronic schizophrenia: a multi-nation, multi-centre, double-blind, parallel-group study vs haloperidol. Br J Psychiatry 1995;166:712-716
9. Dickson RA, Dalby JT, Williams R, et al. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia [letter]. Am J Psychiatry 1995;152:1102-1103
10. Yazigi RA, Quintero CH, Salameh WA. Prolactin disorders. Fertil Steril 1997;67:215-225
11. Corenblum B. Disorders of prolactin secretion. In: Copeland LJ, ed. Textbook of Gynecology, Philadelphia, Pa: WB Saunders Co; 1993:447-467
12. Melmed S, ed. The Pituitary. Cambridge, Mass: Blackwell Science; 1995:149-162
13. Vance ML. New directions in the treatment of hyperprolactinemia. Endocrinologist 1997;7:153-159
14. Corenblum B. Galactorrhea and hyperprolactinemia. Med North Am 1990; 13:1569-1579
15. Windgassen K, Wesselmann U, Schulze Monking H. Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology. Neuropsychobiology 1996;33:142-146
16. Halbreich U, Rojansky N, Palter S, et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995;57:485-491
17. Biller BMK, Baum HBA, Rosenthal DI, et al. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 1992;75:692-697
18. Stampfer MJ, Colditz GA, Willett WC. Menopause and heart disease: a review. Ann N Y Acac Sci 1990;592:193-203
19. Shaarawy M, Nafei S, Abul-Nasr A, et al. Circulating nitric oxide levels in galactorrheic, hyperprolactinemic, amenorrheic women. Fertil Steril 1997; 68:454-459
20. Seeman MV. Psychopathology in men and women: focus on female hormones. Am J Psychiatry 1997:154:1641-1647
21. McEwen BS. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997;48(suppl 7):S8-S15
22. Sherwin BB. Estrogen effects on cognition in menopausal women. Neurology 1997;48(5, suppl 7):S21-S26
23. Cawood EHH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 1996;26:925-936
24. Dickson RA, Glazer WM. Neuroleptic induced hyperprolactinemia. Schizophr Res 1999;35:575-586
25. Ghadirian AM, Chouinard G, Annable L. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 1982;170:463-467
26. Santoni JPH, Saubadu S. Adverse events associated with neuroleptic drugs: focus on neuroendoc rine reactions. Acta Therapeutica 1995;21:193-204
27. Bunker MT, Marken PA, Schneiderhan ME, et al. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine. J Child Adolesc Psychopharmacol 1997;7:65-69
28. Canuso CM, Hanau M, Jhamb KK, et al. Olanzapine use in women with antipsychotic-induced hyperprolactinemia [letter]. Am J Psychiatry 1998; 155:1458
29. Gazzola LR, Opler LA. Return of menstruation after switching from risperidone to olanzapine [letter]. J Clin Psychopharmacol 1998;18:486-487
30. Waldstreicher J, Duffy JF, Brown EN, et al. Gender differences in the temporal organization of prolactin (PRL) secretion: evidence for a sleep-independent circadian rhythm of circulating PRL levels - a clinical research center study. J Clin Endocrinol Metab 1996;81:1483-1487
31. Leibenluft E, Fiero PL, Rubinow DR. Effects of the menstrual cycle on dependent variables in mood disorder research. Arch Gen Psychiatry 1994; 51:761-781
32. Canadian Psychiatric Association. Canadian Clinical Practice Guidelines for the Treatment of Schizophrenia. Can J Psychiatry 1998;43(suppl 2): 25S-40S
33. Beumont PJ, Gelder MG, Friesen GH, et al. The effects of phenothiazines on endocrine function, I: patients with inappropriate lactation and amenorrhoea. Br J Psychiatry 1974;124:413-419
34. Beumont PJV, Corker CS, Friesen HG, et al. The effects of phenothiazines on endocrine function, II: effects in men and post-menopausal women. Br J Psychiatry 1974; 24:420-430
35. Gregory BAJC. The menstrual cycle and its disorders in psychiatric patients, II. J Psychosom Res 1957;2:199-224
36. Crenshaw TL, Coldberg JP. Sexual Pharmacology: Drugs That Affect Sexual Functioning. New York, NY: WW Norton; 1996:307-316
37. Miller LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 1997;23:623-635
38. Currier GW, Simpson GM. Antipsychotic medications and fertility. Psychiatr Serv 1998;49:175-176
39. Dickson RA, Hogg L. Pregnancy of a patient treated with clozapine. Psychiatr Serv 1998;49:1081-1083
40. Kaplan B, Modai I, Stoler M, et al. Clozapine treatment and risk of unplanned pregnancy. J Am Board Fam Pract 1995;8:239-241
41. Dickson RA, Dawson DT. Olanzapine and pregnancy [letter]. Can J Psychiatry 1998;43:2
42. Dickson RA, Edwards A. Clozapine and fertility [letter]. Am J Psychiatry 1997;154:582-583
43. Corenblum B. Rise above normal when treating hyperprolactinemia. Can J Diagnosis 1997;14:133-144
44. Klibanski A, Greenspan SL. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 1986;315:542-546
45. Wesselmann U, Windgassen K. Galactorrhea: subjective response by schizophrenic patients. Acta Psychiatr Scand 1995;91:152-155
46. Buckman MT. Psychological distress in hyperprolactinemic women. In: MacLeod RM, Thorner MO, Scapagnini U. eds. Prolactin: Basic and Clinical Correlates. Padova, Italy: Livana Press; 1985:601-608
47. Seeman MV. The role of estrogen in schizophrenia. J Psychiatry Neurosci 1996;21:123-127
48. Riecher-Rossler A, Hafner H, Stumbaum M, et al. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994;20:203-214
49. Lindamer LA, Lohr JB, Harris MJ, et al. Gender, estrogen, and schizophrenia. Psychopharmacol Bull 1997;33:221-228
50. Kulkarni J, de Castella A, Smith D, et al. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 1996;20:247-252